New data on the effectiveness of liver cell transplantation in patients with Crigler-Najjar syndrome

Citar

Texto integral

Acesso aberto
Acesso é fechado

Acesso está concedido
Acesso é fechado

Acesso é pago ou somente para assinantes

Autor responsável pela correspondência
Email: bozo.ilya@gmail.com

Fox I.S., Chowdhury J.R., Kaufman S.S. et al. Treatment of the Crigler-Najjar syndrom type I with hepatocyte transplantation. Engl. J. Med. 1998; 338: 1422-6.
Kautman S.S., Wood R.P., Show P.W. jr., Markin R.S. Orthotopic liver transplantation for type I Crigler-Najjar syndrome. Hepatology 1986; 6: 1259-62.
Sokal E.M., Silva E.S., Hermans D. Orthotopic liver transplantation for Crigler-Najjar type I disease in six children. Traspant. 1995; 60: 1035—58.
Evans H.M., Kelly D.A., Me Kierman P.S., Hubscher S. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006; 43: 1109-17.
Makouka L., Falk J.A., Falk R.E. Allogenic intrasplenic hepatocyte transplantation. Transplant. Proc. 1987; 19: 1002—3.
Cubero E.S., Maganto P., Ortiz A. Hepatic proliferation in Gunn rats transplanted with hepatocytes. Cell Prolis. 2005; 38; 134-46.
Wu Y.M., Joseph B., Gupta S. Immunosupression using mTOR inhibition mechanism affects replacement of rat liver with transplanted cells. Hepatology 2006; 44: 410—9.
Dixit V., Darnasi R., Arthur M. et al. Cryopreserved microencapsulated hepatocytes-transplantation stadies in Gunn rats. Transplant. 1993; 55: 616—22.
Liu Z.C., Chang T.M. Coencapsulation of hepatocytes and bone marrow stem cells. Int. J. Artif. Organs 2003; 26: 491—7.

Ação

1. JATS XML